Login to Your Account



GenOway Enters Drug Target Deal, Plans $5.4M Financing

By James Etheridge


Wednesday, May 8, 2002
PARIS - GenOway SA signed a nonexclusive agreement with the French pharmaceutical company Servier for the in vivo validation of a number of therapeutic gene targets. (BioWorld International

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription